Ferring Sues Apotex Over DDAVP Generic

Law360, New York (August 22, 2005, 12:00 AM EDT) -- Dutch drug maker Ferring BV is suing a Canadian rival in U.S. district court, asserting a patent for its multipurpose urinary-control drug.

Ferring sued Ontario-based Apotex Inc. in U.S. District Court for the District of New Jersey last week, alleging infringement of the patent used for the tablet version of its desmopressin drug called DDAVP.

Ferring was alerted to generic drug maker Apotex’s intentions when it completed an Abbreviated New Drug Application in July, requesting permission from the U.S. Food and Drug Administration to manufacture and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.